Abstract
Background: Cancer is a major problem which has claimed so many lives throughout the world. Although a number of resources have been utilized for the development of cancer therapeutics, no effective cure has been found so far.
Objective: Therefore, the need for looking at evolving technologies has become very important to get a solution to this problem. Among these, nanotechnology has got so much popularity and became feasible in the past few years. Nanotechnology is presently used as the most preferable drug delivery platform for cancer therapy.
Method: A variety of nanomaterials based on lipid, polymer, metal or magnet have been developed for enhancement of the efficiency of current treatment.
Results: Recently, polymeric-nanoparticles have been exploited as a carrier of many drug substances for invasive and non-invasive routes of delivery.
Conclusion: In this manuscript, the authors have reviewed different aspects of nanoparticles, recent patents and research issues related to cancer.
Keywords: Cancer, patents, polymeric nanoparticles, drug targeting, drug carriers, nanoformulations.
Graphical Abstract
Recent Patents on Nanotechnology
Title:Recent Patents on Polymeric Nanoparticles for Cancer Therapy
Volume: 12 Issue: 2
Author(s): Parijat Pandey and Harish Dureja*
Affiliation:
- Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak- 124001,India
Keywords: Cancer, patents, polymeric nanoparticles, drug targeting, drug carriers, nanoformulations.
Abstract: Background: Cancer is a major problem which has claimed so many lives throughout the world. Although a number of resources have been utilized for the development of cancer therapeutics, no effective cure has been found so far.
Objective: Therefore, the need for looking at evolving technologies has become very important to get a solution to this problem. Among these, nanotechnology has got so much popularity and became feasible in the past few years. Nanotechnology is presently used as the most preferable drug delivery platform for cancer therapy.
Method: A variety of nanomaterials based on lipid, polymer, metal or magnet have been developed for enhancement of the efficiency of current treatment.
Results: Recently, polymeric-nanoparticles have been exploited as a carrier of many drug substances for invasive and non-invasive routes of delivery.
Conclusion: In this manuscript, the authors have reviewed different aspects of nanoparticles, recent patents and research issues related to cancer.
Export Options
About this article
Cite this article as:
Pandey Parijat and Dureja Harish*, Recent Patents on Polymeric Nanoparticles for Cancer Therapy, Recent Patents on Nanotechnology 2018; 12 (2) . https://dx.doi.org/10.2174/1872210512666180327120648
DOI https://dx.doi.org/10.2174/1872210512666180327120648 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Small Molecule Antagonists of the MDM2 Oncoprotein as Anticancer Agents
Current Cancer Drug Targets Virtual Screening and Statistical Analysis in the Design of New Caffeine Analogues Molecules with Potential Epithelial Anticancer Activity
Current Pharmaceutical Design Corticotropin Releasing Factor (CRF) Peptide Family and their Receptors: Divergent Actions Influencing Human Physiology
Current Genomics Diabetes Exacerbates Nanoparticles Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets Metals and Metal Derivatives in Medicine
Mini-Reviews in Medicinal Chemistry Assessment of Thyroid Disorders and Autoimmunity in Patients with Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Neuroendocrine Component in Bladder Tumors
Current Medicinal Chemistry Damage and Recovery of the Bone Marrow Microenvironment Induced by Cancer Chemotherapy – Potential Regulatory Role of Chemokine CXCL12/Receptor CXCR4 Signalling
Current Molecular Medicine Exploration of Metastasis-related Proteins as Biomarkers and Therapeutic Targets in the Treatment of Head and Neck Cancer
Current Cancer Drug Targets The Price of the Successful Treatment of Pediatric Malignancies
Current Pediatric Reviews VIP and Drug Design
Current Pharmaceutical Design A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer
Current Drug Targets Correlating Low-Similarity Peptide Sequences and Allergenic Epitopes
Current Pharmaceutical Design Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]
Current Pharmaceutical Design The Sequence Specificity of the Anti-tumour Drug, Cisplatin, in Telomeric DNA Sequences Compared with Consecutive Guanine DNA Sequences
Anti-Cancer Agents in Medicinal Chemistry The University of New Mexico Center for Molecular Discovery
Combinatorial Chemistry & High Throughput Screening Editorial [Hot Topic: Targeting G Protein and Phosphorylation Dependent Signalling Molecules for Anticancer Therapy (Guest Editor: Jeyanthy Eswaran)]
Anti-Cancer Agents in Medicinal Chemistry Effects of PPARγ Agonists against Vascular and Renal Dysfunction
Current Molecular Pharmacology Quantifying Gp96/Grp94 Complexes Preparations for Vaccines: a Key Step Often Inaccurate
Current Medicinal Chemistry Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Current Pharmaceutical Design